Retinopathy of Prematurity (ROP) is a leading cause of preventable childhood blindness, yet many preterm infants miss timely screening due to a shortage of specialists, high equipment costs, and slow screening workflows. Most NICUs lack access to affordable, easy-to- use retinal imaging systems, making early detection difficult at scale.​

Neubo 130 closes this gap by enabling high-quality ROP screening at the point of care. Designed for neonatal use, it delivers ultra-widefield retinal images and uses AI to quickly identify ROP and Plus disease. The system can be operated by trained non-specialists, making screening faster, more accessible, and scalable across NICUs and large ROP programs, so more infants receive timely diagnosis and treatment.​ ​